AstraZeneca launches integrated genomics approach to transform drug discovery and development
|
22 April 2016 |
AstraZeneca and Eli Lilly and Company announce continuation of pivotal clinical trial for people with early Alzheimer's disease
|
08 April 2016 |
Pandemic influenza vaccine receives positive CHMP opinion
|
01 April 2016 |
Brilinta preferred over clopidogrel in updated American College of Cardiology and American Heart Association guideline in acute coronary syndrome
|
31 March 2016 |
AstraZeneca reports top-line results from the Brilinta SOCRATES trial in stroke
|
23 March 2016 |
AstraZeneca's potential medicine for neuromyelitis optica receives FDA Orphan Drug Designation
|
09 March 2016 |
AstraZeneca enters licensing agreement with China Medical System Holdings for hypertension medicine
|
29 February 2016 |
Acalabrutinib recommended for orphan drug designation in Europe for three indications
|
26 February 2016 |
Brilique (ticagrelor) approved in EU for extended treatment of patients with history of heart attack
|
19 February 2016 |
AstraZeneca and Moderna Therapeutics announce new collaboration to co-develop and co-commercialise immuno-oncology mRNA therapeutics™
|
12 January 2016 |